Last updated: October 25, 2022
Sponsor: Chan Joon Kim
Overall Status: Active - Recruiting
Phase
N/A
Condition
Blood Clots
Hypercholesterolemia
Myocardial Ischemia
Treatment
N/AClinical Study ID
NCT05599152
CKD-HIRA-Data-Review
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients who have a diagnosis code for acute myocardial infarction indicated in theNational Health Insurance data and data for drugs that have used ticagrelor/prasugrelfor 30-90 days when hospitalized for the relevant disease.
- Patients who switched to clopidogrel after 30-90 days.
- Patients with a diagnosis code for Venus myocardial infarction and a prescription codefor percutaneous cardiovascular intervention in the National Health Insurance data.
- Adults 18 years of age or older
Exclusion
Exclusion Criteria:
- A person who has data for requesting blood transfusion during the period ofhospitalization in the National Health Insurance data
- Those who have data for oral anticoagulants (warfarin, Coumadin, apixaban, edoxaban,dabigatran, rivaroxaban) in the National Health Insurance data
- Those who have a diagnosis code for malignant tumor in the National Health Insurancedata
- Those who have end-stage renal failure code in the National Health Insurance data orthose who have data for hemo/peritoneal dialysis
- A person who has a request for blood transfusion during the period of usingTicagrelor/prasugrel
Study Design
Total Participants: 3000
Study Start date:
May 21, 2020
Estimated Completion Date:
November 30, 2022
Study Description
Connect with a study center
The Catholic University of Korea, Uijeongbu ST. Mary's Hospital
Uijeongbu, 11765
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.